Search Within

Sloane Camille Baptiste Smith

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (6)
  2. Epidemiology and Biostatistics (6)
  3. Department of Medicine (5)
  4. Population Sciences Research Program (5)
  5. Solid Tumor Oncology Division (5)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Anne Fusco (3)
  2. David Kelsen (3)
  3. Eileen O'Reilly (3)
  4. Ellen Hollywood (3)
  5. Kenneth Yu (3)
  6. Kinh Gian Do (3)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2015 (2)
  4. 2014 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. European Journal of Cancer (1)
  3. Journal of Cancer Research and Clinical Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (1)
  3. Springer (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Shoushtari, A.; Li, Y.; Paucar, D. J.; Smith, S. C.; Kudchadkar, R. R.; Doyle, A.; Sosman, J. A.; Quevedo, J. F.; more...
    Journal of Cancer Research and Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Relationship between physician-adjudicated adverse events (AE) and patient-reported health-related quality of life (HRQoL) in a phase II clinical trial of patients (pts) with metastatic uveal melanoma (UM)
    Meeting Abstract

    Atkinson, T. M.; Hay, J. L.; Doyle, L. A.; Paucar, D.; Smith, S. C.; Li, Y. L.; Carvajal, R. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
    Meeting Abstract

    Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save